Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 41

1.

Metabolic Tumor Volume on 18F-FDG PET/CT Improves Preoperative Identification of High-Risk Endometrial Carcinoma Patients.

Husby JA, Reitan BC, Biermann M, Trovik J, Bjørge L, Magnussen IJ, Salvesen ØO, Salvesen HB, Haldorsen IS.

J Nucl Med. 2015 Aug;56(8):1191-8. doi: 10.2967/jnumed.115.159913. Epub 2015 Jun 4.

2.

Tumour apparent diffusion coefficient is associated with depth of myometrial invasion and is negatively correlated to tumour volume in endometrial carcinomas.

Husby JA, Salvesen ØO, Magnussen IJ, Trovik J, Bjørge L, Salvesen HB, Haldorsen IS.

Clin Radiol. 2015 May;70(5):487-94. doi: 10.1016/j.crad.2014.12.016. Epub 2015 Jan 30.

PMID:
25639620
3.

Preoperative tumor size at MRI predicts deep myometrial invasion, lymph node metastases, and patient outcome in endometrial carcinomas.

Ytre-Hauge S, Husby JA, Magnussen IJ, Werner HM, Salvesen ØO, Bjørge L, Trovik J, Stefansson IM, Salvesen HB, Haldorsen IS.

Int J Gynecol Cancer. 2015 Mar;25(3):459-66. doi: 10.1097/IGC.0000000000000367.

4.

Increased microvascular proliferation is negatively correlated to tumour blood flow and is associated with unfavourable outcome in endometrial carcinomas.

Haldorsen IS, Stefansson I, Grüner R, Husby JA, Magnussen IJ, Werner HM, Salvesen ØO, Bjørge L, Trovik J, Taxt T, Akslen LA, Salvesen HB.

Br J Cancer. 2014 Jan 7;110(1):107-14. doi: 10.1038/bjc.2013.694. Epub 2013 Oct 31.

5.

Dynamic contrast-enhanced MRI in endometrial carcinoma identifies patients at increased risk of recurrence.

Haldorsen IS, Grüner R, Husby JA, Magnussen IJ, Werner HM, Salvesen OO, Bjørge L, Stefansson I, Akslen LA, Trovik J, Taxt T, Salvesen HB.

Eur Radiol. 2013 Oct;23(10):2916-25. doi: 10.1007/s00330-013-2901-3. Epub 2013 Jun 4.

PMID:
23732687
6.

Magnetic resonance imaging performs better than endocervical curettage for preoperative prediction of cervical stromal invasion in endometrial carcinomas.

Haldorsen IS, Berg A, Werner HM, Magnussen IJ, Helland H, Salvesen OO, Trovik J, Salvesen HB.

Gynecol Oncol. 2012 Sep;126(3):413-8. doi: 10.1016/j.ygyno.2012.05.009. Epub 2012 May 15.

PMID:
22609110
7.

Standard 1.5-T MRI of endometrial carcinomas: modest agreement between radiologists.

Haldorsen IS, Husby JA, Werner HM, Magnussen IJ, Rørvik J, Helland H, Trovik J, Salvesen ØO, Espeland A, Salvesen HB.

Eur Radiol. 2012 Jul;22(7):1601-11. doi: 10.1007/s00330-012-2400-y. Epub 2012 Mar 28.

PMID:
22453859
8.

Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials.

Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, Grotta JC, Albers GW, Kaste M, Marler JR, Hamilton SA, Tilley BC, Davis SM, Donnan GA, Hacke W; ECASS, ATLANTIS, NINDS and EPITHET rt-PA Study Group, Allen K, Mau J, Meier D, del Zoppo G, De Silva DA, Butcher KS, Parsons MW, Barber PA, Levi C, Bladin C, Byrnes G.

Lancet. 2010 May 15;375(9727):1695-703. doi: 10.1016/S0140-6736(10)60491-6.

PMID:
20472172
9.

[Surgical treatment of vaginal agenesia].

Sivertsen A, Gravem PE, Johnsen SL, Magnussen IJ, Søvik O.

Tidsskr Nor Laegeforen. 2001 Sep 30;121(23):2703-5. Norwegian.

10.

Evaluating patients with vertebrobasilar transient ischemic attacks.

Haase J, Magnussen IB, Ogilvy CS, Ojemann RG, Meyer FB, Quest DO, Lawton MT, McDougall CG, Spetzler RF, Samson D, Takahashi A, Yoshimoto T, Ausman JI, Charbel FT, Debrun G, Aletich V, Dujovny M.

Surg Neurol. 1999 Oct;52(4):386-92. No abstract available.

PMID:
10555845
11.

Transcutaneous abdominal ultrasonography in the staging of lung cancer.

Bakke PS, Taule M, Lillo E, Melgren G, Magnussen IJ, Halvorsen OJ.

Thorax. 1997 Mar;52(3):276-80.

12.
13.

p,p'-DDT-induced myoclonus in mice: the effect of enhanced 5-HT neurotransmission.

Magnussen I.

Acta Pharmacol Toxicol (Copenh). 1985 Feb;56(2):87-90.

PMID:
2986413
14.

Effects of carbidopa on the cerebral accumulation of exogenous L-5-hydroxytryptophan in mice.

Magnussen I.

Acta Pharmacol Toxicol (Copenh). 1984 Sep;55(3):199-202.

PMID:
6334429
15.

Fluoxetine in the treatment of intention myoclonus.

Van Woert MH, Magnussen I, Rosenbaum D, Chung E.

Clin Neuropharmacol. 1983 Mar;6(1):49-54.

PMID:
6189599
16.

Pharmacokinetics and bioavailability of intravenous and intramuscular lorazepam with an adjunct test of the inattention effect in humans.

Nielsen-Kudsk F, Jensen TS, Magnussen I, Jakobsen P, Jensen PB, Mondrup K, Petersen T.

Acta Pharmacol Toxicol (Copenh). 1983 Feb;52(2):121-7.

PMID:
6133404
17.

Palatal myoclonus during sleep.

Kayed K, Sjaastad O, Magnussen I, Mårvik R.

Sleep. 1983;6(2):130-6.

PMID:
6878982
18.

Treatment of myoclonic syndromes with paroxetine alone or combined with 5-HTP.

Magnussen I, Mondrup K, Engbaek F, Lademann A, Olivarius BD.

Acta Neurol Scand. 1982 Aug;66(2):276-82. No abstract available.

PMID:
6215817
19.

Study of serotonin in neuropsychiatric disorders.

Van Woert MH, Magnussen I, Lowe YH, Hwang EC.

J Histochem Cytochem. 1982 Aug;30(8):824-7. No abstract available.

PMID:
6181125
20.

Human pharmacokinetics of long term 5-hydroxytryptophan combined with decarboxylase inhibitors.

Magnussen I, Van Woert MH.

Eur J Clin Pharmacol. 1982;23(1):81-6.

PMID:
6182005

Supplemental Content

Loading ...
Support Center